170 related articles for article (PubMed ID: 36422506)
1. Residual neuromuscular block in the postanesthesia care unit: incidence, risk factors, and effect of neuromuscular monitoring and reversal agents.
Özbey NB; Abdullah T; Deligöz Ö
Turk J Med Sci; 2022 Oct; 52(5):1656-1664. PubMed ID: 36422506
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study.
Domenech G; Kampel MA; García Guzzo ME; Novas DS; Terrasa SA; Fornari GG
BMC Anesthesiol; 2019 Aug; 19(1):143. PubMed ID: 31390986
[TBL] [Abstract][Full Text] [Related]
3. Residual neuromuscular blockade in a real life clinical setting: correlation with sugammadex or neostigmine administration.
Batistaki C; Tentes P; Deligiannidi P; Karakosta A; Florou P; Kostopanagiotou G
Minerva Anestesiol; 2016 May; 82(5):550-8. PubMed ID: 26394365
[TBL] [Abstract][Full Text] [Related]
4. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
[TBL] [Abstract][Full Text] [Related]
5. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O
J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097
[TBL] [Abstract][Full Text] [Related]
6. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
7. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
[TBL] [Abstract][Full Text] [Related]
8. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and outcomes of residual neuromuscular blockade: A systematic review of observational studies.
Raval AD; Anupindi VR; Ferrufino CP; Arper DL; Bash LD; Brull SJ
J Clin Anesth; 2020 Nov; 66():109962. PubMed ID: 32585565
[TBL] [Abstract][Full Text] [Related]
11. Half-Dose Sugammadex After Neostigmine Versus Neostigmine as a Routine Reversal Agent: A Pilot Randomized Trial.
Baysal A; Sagıroglu G; Dogukan M; Ozkaynak I
J Perianesth Nurs; 2022 Jun; 37(3):326-332. PubMed ID: 35153119
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a Protocol for the Management of Maintenance and Reversal of Rocuronium Block Using Neostigmine or Sugammadex.
Thilen SR; Liang T; Kruse TN; Cain KC; Treggiari MM; Bhananker SM
Anesth Analg; 2023 Jun; 136(6):1143-1153. PubMed ID: 37205804
[TBL] [Abstract][Full Text] [Related]
13. Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study.
Gonçalves PMSE; Vieira AV; Silva CHRD; Gomez RS
Braz J Anesthesiol; 2021; 71(1):38-43. PubMed ID: 33712250
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
Hristovska AM; Duch P; Allingstrup M; Afshari A
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular and Clinical Recovery in Thoracic Surgical Patients Reversed With Neostigmine or Sugammadex.
Murphy GS; Avram MJ; Greenberg SB; Bilimoria S; Benson J; Maher CE; Teister KJ; Szokol JW
Anesth Analg; 2021 Aug; 133(2):435-444. PubMed ID: 33323787
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a novel clinical score to estimate the risk of REsidual neuromuscular block Prediction Score and the last train-of-four count documented in the electronic anaesthesia record: A retrospective cohort study of electronic data on file.
Rudolph MI; Ng PY; Deng H; Scheffenbichler FT; Grabitz SD; Wanderer JP; Houle TT; Eikermann M
Eur J Anaesthesiol; 2018 Nov; 35(11):883-892. PubMed ID: 30020144
[TBL] [Abstract][Full Text] [Related]
17. A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.
Insinga RP; Joyal C; Goyette A; Galarneau A
BMC Anesthesiol; 2016 Nov; 16(1):114. PubMed ID: 27852231
[TBL] [Abstract][Full Text] [Related]
18. Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials.
Raval AD; Uyei J; Karabis A; Bash LD; Brull SJ
J Clin Anesth; 2020 Apr; 64():109818. PubMed ID: 32304958
[TBL] [Abstract][Full Text] [Related]
19. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
[TBL] [Abstract][Full Text] [Related]
20. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
